Asthma Clinical Trials

Showing 3221-3240 of 4,312 trials

Efficacy and Safety Study in Subjects With Asthma

NCT00980200

The study is a multi-center, double-blind, placebo-controlled, cross-over study to evaluate the efficacy and safety of selected doses and dose intervals of the novel long acting beta agonist (LABA), GW642444 in asthmatic subjects ≥18 years of age who are currently receiving inhaled corticosteroid treatment.

Asthma

GlaxoSmithKline75 participantsStarted Sep 2009

Cypress, California, United States • Huntington Beach, California, United States • Bethesda, Maryland, United States +6 more locations

UNKNOWN

Respiratory Muscle Strength and Function in Neuromuscular Disorders and Chronic Obstructive Pulmonary Disease

NCT03032562

Using an extensive set of both volitional and non-volitional tests of respiratory muscle function and strength it is the aim of this study to * identify disease-specific patterns of respiratory muscle impairment in different NMD and COPD * establish which set of tests is predictive of sleep-disordered breathing or daytime hypercapnia in patients with NMD or COPD, respectively. * to investigate the decline of respiratory muscle function in patients with progressive NMD and COPD along with sleep studies and capnography

Respiratory Muscle Paralysis

Universität Münster200 participantsStarted Dec 2016

Münster, North Rhine-Westphalia, Germany • Solingen, North Rhine-Westphalia, Germany

Efficacy and Safety Study in Subjects With Asthma

Respiratory Muscle Strength and Function in Neuromuscular Disorders and Chronic Obstructive Pulmonary Disease

Related Searches

Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist

Buteyko Method for Children With Asthma

Strict Glucose Control of Pediatric Intensive Care Unit (ICU) Patients

Study Of Asthma In Patients Of African Descent

Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)

Comparing the Efficacy of Bricanyl M2 and Bricanyl M3 at 0.5 and 1.5 mg Dose Levels, to Allow for a Switch From Bricanyl Turbuhaler M2 to Bricanyl Turbuhaler M3

Volontary Inspiratory Muscles Measures Compared With Phrenic Nerves Magnetic Stimulations Measures

Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics

Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents

To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler in Subjects With Asthma

The Effects of a Standardized Management Plan on Children With Critical Asthma

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.

A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease

Pulmonary Pathophysiology and Inflammatory Response in Patients Treated With Ecmo for Severe Respiratory Failure

Study Of Fluticasone Propionate/Salmeterol In Asthmatic Subjects

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.

Expansion of the COPD At-risk Module in 4 States BRFSS Telephone Health Surveys